STRATEGIES & TECHNOLOGIES DRIVING DRUG DISCOVERY TO MARKET

Welcome to World Congress on Drug Discovery & Development-2016

After the grand success of Global Cancer Summit-2015, BioGenesis Health Cluster is pleased to announce the “World Congress on Drug Discovery & Development-2016”, which is scheduled on 23rd, 24th & 25th November 2016 at J.N.TATA Auditorium, Indian Institute of Science, Bengaluru, Karnataka, India.

The Drug Discovery & Development-2016 conference brings together a host of senior level experts to discuss recent developments in the industry and debate the best strategies and solutions to improve drug discovery going forward. The conference will host more than 200world-class speakers from academia and industry who will discuss recent advances in basic and translational aspects of drug discovery. This conference will highlight the latest scientific breakthroughs, explore innovative technologies and approaches that can be used to overcome drug development challenges, and bring together industry leaders who will discuss future opportunities for novel therapeutic discovery.

The scientific program will feature live workshops, interactive education sessions, B2B meetings, round-table discussions apart from the conventional plenary sessions, featured symposia, break out sessions and oral presentation sessions for abstracts and challenging cases.

Enquiry


Who Should Attend

  • Academic and Industrial Scientists Associated with Discovery...
Read More

Focus Of The Conference

  • To cast light on pharmacokinetics and pharmacodynamics...
Read More

Benefits Of Attending

  • Exchange ideas and network with leading pharmaceutical...
Read More

Summary

  • Third largest pharmaceuticals market by 2020 in terms of incremental growth
Read More

Financial Support

  • SETU (Self Employment and Talent Utilization) to be established as a techno-financial...
Read More

Investment Opportunities

  • India is expected to be the third largest global market for active pharmaceutical...
Read More
Welcome Message From Chairman


Dr. MUR Naidu,

M.D. F.C.C.P, FIPS, Dean, Faculty of Medicine Professor and Head Dept. of Clinical Pharmacology & Therapeutics
The Nizam's Institute of Medical Sciences, Hyderabad- 400082 India.










Dear Colleagues,

The conference aims to provide many interesting perspectives on how science and technology of drug discovery and drug therapy are changing rapidly, thereby providing new opportunities and challenges to the scientists and medical doctors.

The major topics of discussion related to drug, discovery and therapy will include: Pharmaceutical Research & Development, Translational Medicine, Regenerative Medicine, Enabling Technologies, Structural Biology, Drug Delivery & Targeting, Antiinfectives, Biologics, CNS Drug Discovery & Therapy, Diabetes and Obesity Drug Discovery & Therapy, Women's Health Drug Discovery & Therapy, Drug Discovery in Preclinical Research, Cardiovascular Drug Discovery & Therapy, Oncology, Process Chemistry and Drug Manufacturing, Pulmonary Drug Discovery & Therapy, Recent Advances in Patient Treatment and Care, Inflammation and Immunology, Innovative Drug Discovery and Nanotechnology, Pharmaceutical Biotechnology, Proteomics & Bioinformatics, Pharmacogenomics, Protein and Peptide Sciences, Drug Metabolism, Hot Topics in Medicinal Chemistry, Medical Imaging, Hot Topics in HIV Research, In-silico Drug Design and in-silico screening, Combinatorial Chemistry, High-throughput Screening & Laboratory automation, Hot Topics in Drug Targets, Hot Topics in Natural Products, Stereoselective Synthesis of Bioactive Compounds, Recent Advances in Spectroscopy, Academic CRO/Industrial collaborations in drug discovery.

I look forward to welcoming the participants to this exciting conference which will bring together world leaders in their respective fields in the fascinating environment of Bengaluru. The state of Karnataka is one of the prominent tourism hubs in India.

Dr. MUR NAIDU
Chairman
World Congress on Drug discovery & Development -2016

Welcome Message from Co-chairman


Dr.Richard Hopkinson,

University of Oxford
USA.











Dear Colleagues,

Interactive Streams of the Conference:

  • Target Based Discovery
  • Screening & Assays: Enabling Technologies
  • Discovery Chemistry & Drug Design
  • Supporting Innovation: Translational Approaches & Informatics Tools

Our Congress brings together a host of senior levelexperts to discuss recent developments in the industryand debate the best strategies and solutions toimprove drug discovery going forward. The drug discovery landscape is changing rapidly. Withthe cost of bringing a drug to market rising, researchers are seeking innovative ways to increasethe efficiency of their R&D pipelines. On the first day ofour Drug Discovery INDIA Congress our expert panel ofspeakers will address the current strategies fordirected discovery, including the resurgence ofphenotypic screening and comparing its utility withtarget based discovery.
Our renowned speakers will explore novel peptidedrug discovery, strategies for target selection and incorporating genomic technologies into discoveryresearch.

Dr.Richard Hopkinson,
Co Chairman,
World Congress on Drug Discovery and Development - 2016

Welcome Message From Co-Chairman (Technical Coordinator)


Dr. Rer.Nat.Shibashish Giri,

Applied Stem Cell Biology and Cell Technology, Biomedical and Biotechnological Centre (BBZ), Medical Faculty, University of Leipzig, Germany.











Dear Colleagues,

On behalf of the organizing committee, I am honoured and delighted to welcome you to the World Congress on Drug Discovery and Development to be held from the 23rd, 24th & 25th November 2016 at J.N.TATA Auditorium, Indian Institute of Science, Bengaluru, Karnataka.

Our technical program is rich and varied with 5 keynote speech and 30 invited talks and around 240 technical papers split between 3 parallel oral sessions and 3 poster sessions each day. Besides, there are 4 workshops and a tutorial program co-located. We also expect to provide Technical demonstrations and numerous opportunities for informal networking.

As a conference chair of World Congress on Drug Discovery and Development, I know that the success of the conference depends ultimately on the many people who have worked with us in planning and organizing both the technical program and supporting social arrangements. In particular, we thank the Program Chairs for their wise advice and brilliant suggestion on organizing the technical program the Program Committee for their thorough and timely reviewing of the papers, and our sponsors who have helped us to keep down the costs of World Congress on Drug Discovery and Development for all participants. Recognition should go to the Local Organizing Committee members who have all worked extremely hard for the details of important aspects of the conference programs and social activities.



Dr. Rer.Nat.Shibashish Giri,
Co-Chairman (Technical Coordinator),
World Congress on Drug Discovery and Development - 2016

Invitation


Dr.V.P.Rao,

Chairman,
BioGenesis Health Cluster










It is my pleasure to welcome you to the World Congress on Drug Discovery and Development to be held from the 23rd, 24th & 25th November 2016 at J.N.TATA Auditorium, Indian Institute of Science, Bengaluru, Karnataka.

The current pharmaceutical industry business model is both economically unsustainable and operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets. In order to make the most of these future growth opportunities, the industry must fundamentally change the way it operates. Most Big Pharma companies have traditionally done everything from research and development (R&D) through to commercialization themselves. However, by 2020 this model will no longer work for many organizations. If they are to prosper, they will need to improve their R&D productivity, reduce their costs, tap the potential of the emerging economies and switch from selling medicines to managing outcomes.

Drug discovery represents the first step in the creation of new drugs, and takes place in academic institutions, biotech companies, and large pharmaceutical corporations. Until recently, these sectors have each operated independently with little collaboration between those at the forefront of discovery research and those with experience in developing drugs. With the rise of translational research these relationships are shifting and new hubs are emerging, as key players seek to pool the expertise necessary to generate new therapies by linking laboratory discoveries directly to unmet clinical needs. BioGenesis Health Cluster aims at creating an international platform to discuss modern trends and increasing adoption of translational research, which can lead to novel integrated discovery nexuses that may change the landscape of drug discovery.

The conference aims to provide many interesting perspectives on how science and technology of drug discovery & development are changing rapidly, thereby providing new opportunities and challenges to scientists and medical doctors.

We hope the program of plenary lectures, symposia and workshops, oral presentations and posters will be scientifically stimulating and lead to new collaborations and research opportunities. We welcome our many international guests and hope you enjoy the meeting and your visit to Bengaluru.

Dr.V.P.Rao,
Chairman,
BioGenesis Health Cluster

Organizers

Supporters

Country Partners

Branding Partners